Augmentin and Mean cell haemoglobin concentration decreased - a phase IV clinical study of FDA data
Summary:
Mean cell haemoglobin concentration decreased is reported as a side effect among people who take Augmentin (amoxicillin; clavulanate potassium), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Oxycontin, and have Pain.
The phase IV clinical study analyzes which people have Mean cell haemoglobin concentration decreased when taking Augmentin. It is created by eHealthMe based on reports of 41,293 people who have side effects when taking Augmentin from the FDA, and is updated regularly.
What is Augmentin?
Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.
What is Mean cell haemoglobin concentration decreased?
Mean cell haemoglobin concentration decreased (less concentration of haemoglobin in a given volume of packed red blood cells) is found to be associated with 316 drugs and 374 conditions by eHealthMe. Check the latest studies of Mean cell haemoglobin concentration decreased.
41,293 people reported to have side effects when taking Augmentin.
Among them, 11 people (0.03%) have Mean cell haemoglobin concentration decreased.
Among these 11 people:
How long have people been on Augmentin when they have Mean cell haemoglobin concentration decreased? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Mean cell haemoglobin concentration decreased when taking Augmentin? *
- female: 72.73 %
- male: 27.27 %
What is the age of people who have Mean cell haemoglobin concentration decreased when taking Augmentin? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 50.0 %
- 30-39: 0.0 %
- 40-49: 12.5 %
- 50-59: 0.0 %
- 60+: 37.5 %
What are other drugs people take besides Augmentin? *
- Lyrica: 5 people, 45.45%
- Oxycontin: 5 people, 45.45%
- Lansoprazole: 3 people, 27.27%
- Actiq: 3 people, 27.27%
- Ambien: 3 people, 27.27%
- Norco: 3 people, 27.27%
- Casodex: 3 people, 27.27%
- Macrodantin: 3 people, 27.27%
- Cymbalta: 3 people, 27.27%
- Flexeril: 3 people, 27.27%
What are other side effects people have besides Mean cell haemoglobin concentration decreased? *
- Haemoglobin Decreased: 8 people, 72.73%
- Blood Alkaline Phosphatase Increased: 7 people, 63.64%
- Gamma-Glutamyltransferase Increased: 7 people, 63.64%
- White Blood Cell Count Increased: 5 people, 45.45%
- Eosinophil Count Decreased: 4 people, 36.36%
- Liver Disorder (liver diseases): 4 people, 36.36%
- Iron Binding Capacity Total Increased: 4 people, 36.36%
- Hepatic Fibrosis (scarring process that represents the liver's response to injury): 4 people, 36.36%
- Gamma-Glutamyltransferase Decreased: 4 people, 36.36%
- Chronic Hepatitis (long lasting inflammation of liver): 4 people, 36.36%
What are the existing conditions these people have? *
- Pain: 6 people, 54.55%
- Toothaches (tooth pain): 4 people, 36.36%
- Stress And Anxiety: 2 people, 18.18%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 18.18%
- Muscle Spasms (muscle contraction): 2 people, 18.18%
- Hypotension (abnormally low blood pressure): 1 person, 9.09%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 9.09%
- Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 9.09%
- Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 1 person, 9.09%
- Cardiac Failure: 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Augmentin and have Mean cell haemoglobin concentration decreased?
- Check whether Mean cell haemoglobin concentration decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Augmentin:
- Augmentin (42,620 reports)
Mean cell haemoglobin concentration decreased treatments and more:
- Mean cell haemoglobin concentration decreased (2,082 reports)
How severe was Mean cell haemoglobin concentration decreased and when was it recovered:
Expand to all the drugs that have ingredients of amoxicillin; clavulanate potassium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Augmentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Mean cell haemoglobin concentration decreased:
- Mean cell haemoglobin concentration decreased (316 drugs)
Browse all the conditions that are associated with Mean cell haemoglobin concentration decreased:
- Mean cell haemoglobin concentration decreased (374 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium (the active ingredients of Augmentin) and Augmentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Phenazopyridine Hcl and Skelaxin - now
- Drug interactions of Simponi and Triprolidine Hydrochloride - 3 seconds ago
- Weight Loss and Obsessive-Compulsive Disorder - 9 seconds ago
- Drug interactions of Veltassa and Neoral - 14 seconds ago
- Could Lyrica cause Chronic Obstructive Pulmonary Disease? - 21 seconds ago
- Could Arginine cause Weakness? - 54 seconds ago
- Could Tanzeum cause Itching? - 55 seconds ago
- Drug interactions of Fenofibrate and Azathioprine Sodium - a minute ago
- Fentanyl-25 vs. Cannabis, side effect and effectiveness comparison - a minute ago
- Could Triamterene cause Therapeutic Response Unexpected? - a minute ago